These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 24284293)

  • 1. Effects of broad-spectrum antimycobacterial therapy on chronic pulmonary sarcoidosis.
    Drake WP; Richmond BW; Oswald-Richter K; Yu C; Isom JM; Worrell JA; Shipley GR
    Sarcoidosis Vasc Diffuse Lung Dis; 2013 Nov; 30(3):201-11. PubMed ID: 24284293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II Investigation of the Efficacy of Antimycobacterial Therapy in Chronic Pulmonary Sarcoidosis.
    Drake WP; Culver DA; Baughman RP; Judson MA; Crouser ED; James WE; Ayers GD; Ding T; Abel K; Green A; Kerrigan A; Sesay A; Bernard GR
    Chest; 2021 May; 159(5):1902-1912. PubMed ID: 33387486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The St. George's Respiratory Questionnaire in Pulmonary Sarcoidosis.
    Lo KH; Donohue J; Judson MA; Wu Y; Barnathan ES; Baughman RP;
    Lung; 2020 Dec; 198(6):917-924. PubMed ID: 32979072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral antimycobacterial therapy in chronic cutaneous sarcoidosis: a randomized, single-masked, placebo-controlled study.
    Drake WP; Oswald-Richter K; Richmond BW; Isom J; Burke VE; Algood H; Braun N; Taylor T; Pandit KV; Aboud C; Yu C; Kaminski N; Boyd AS; King LE
    JAMA Dermatol; 2013 Sep; 149(9):1040-9. PubMed ID: 23863960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Pilot Randomized Trial of Transdermal Nicotine for Pulmonary Sarcoidosis.
    Crouser ED; Smith RM; Culver DA; Julian MW; Martin K; Baran J; Diaz C; Erdal BS; Hade EM
    Chest; 2021 Oct; 160(4):1340-1349. PubMed ID: 34029565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial.
    Maher TM; Corte TJ; Fischer A; Kreuter M; Lederer DJ; Molina-Molina M; Axmann J; Kirchgaessler KU; Samara K; Gilberg F; Cottin V
    Lancet Respir Med; 2020 Feb; 8(2):147-157. PubMed ID: 31578169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-reactive protein predicts response to infliximab in patients with chronic sarcoidosis.
    Sweiss NJ; Barnathan ES; Lo K; Judson MA; Baughman R;
    Sarcoidosis Vasc Diffuse Lung Dis; 2010 Jul; 27(1):49-56. PubMed ID: 21086905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Six-minute walk test and health status assessment in sarcoidosis.
    Baughman RP; Sparkman BK; Lower EE
    Chest; 2007 Jul; 132(1):207-13. PubMed ID: 17625083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of a randomized controlled trial to evaluate effectiveness of methotrexate versus prednisone as first-line treatment for pulmonary sarcoidosis: the PREDMETH study.
    Kahlmann V; Janssen Bonás M; Moor CC; van Moorsel CHM; Kool M; Kraaijvanger R; Grutters JC; Overgaauw M; Veltkamp M; Wijsenbeek MS;
    BMC Pulm Med; 2020 Oct; 20(1):271. PubMed ID: 33076885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical Activity and Fatigue in Patients with Sarcoidosis.
    Bahmer T; Watz H; Develaska M; Waschki B; Rabe KF; Magnussen H; Kirsten D; Kirsten AM
    Respiration; 2018; 95(1):18-26. PubMed ID: 29131111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement.
    Baughman RP; Drent M; Kavuru M; Judson MA; Costabel U; du Bois R; Albera C; Brutsche M; Davis G; Donohue JF; Müller-Quernheim J; Schlenker-Herceg R; Flavin S; Lo KH; Oemar B; Barnathan ES;
    Am J Respir Crit Care Med; 2006 Oct; 174(7):795-802. PubMed ID: 16840744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of pulmonary rehabilitation in exercise capacity and quality of life in chronic obstructive pulmonary disease patients with and without global fat-free mass depletion.
    Berton DC; Silveira L; Da Costa CC; De Souza RM; Winter CD; Zimermann Teixeira PJ
    Arch Phys Med Rehabil; 2013 Aug; 94(8):1607-14. PubMed ID: 23416765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy Results of a 52-week Trial of Adalimumab in the Treatment of Refractory Sarcoidosis.
    Sweiss NJ; Noth I; Mirsaeidi M; Zhang W; Naureckas ET; Hogarth DK; Strek M; Caligiuri P; Machado RF; Niewold TB; Garcia JG; Pangan AL; Baughman RP
    Sarcoidosis Vasc Diffuse Lung Dis; 2014 Apr; 31(1):46-54. PubMed ID: 24751453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nutritional supplementation for stable chronic obstructive pulmonary disease.
    Ferreira IM; Brooks D; White J; Goldstein R
    Cochrane Database Syst Rev; 2012 Dec; 12():CD000998. PubMed ID: 23235577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationships among dyspnoea, health-related quality of life and psychological factors in sarcoidosis.
    de Boer S; Kolbe J; Wilsher ML
    Respirology; 2014 Oct; 19(7):1019-24. PubMed ID: 25123812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of home-based pulmonary rehabilitation for patients with chronic obstructive pulmonary disease: a meta-analysis of randomized controlled trials.
    Liu XL; Tan JY; Wang T; Zhang Q; Zhang M; Yao LQ; Chen JX
    Rehabil Nurs; 2014; 39(1):36-59. PubMed ID: 23780865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Exercise Training on Cardiopulmonary Function and Quality of Life in Elderly Patients with Pulmonary Fibrosis: A Meta-Analysis.
    Li X; Yu R; Wang P; Wang A; Huang H
    Int J Environ Res Public Health; 2021 Jul; 18(14):. PubMed ID: 34300094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of response to pulmonary rehabilitation in stable chronic obstructive pulmonary disease patients: A prospective cohort study.
    Ragaselvi S; Janmeja AK; Aggarwal D; Sidana A; Sood P
    J Postgrad Med; 2019; 65(2):101-106. PubMed ID: 31036780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhaled iloprost for sarcoidosis associated pulmonary hypertension.
    Baughman RP; Judson MA; Lower EE; Highland K; Kwon S; Craft N; Engel PJ
    Sarcoidosis Vasc Diffuse Lung Dis; 2009 Jul; 26(2):110-20. PubMed ID: 20560291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in symptom severity and health status impairment between patients with pulmonary and pulmonary plus extrapulmonary sarcoidosis.
    Gvozdenovic BS; Mihailovic-Vucinic V; Ilic-Dudvarski A; Zugic V; Judson MA
    Respir Med; 2008 Nov; 102(11):1636-42. PubMed ID: 18691860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.